142 related articles for article (PubMed ID: 27981925)
21. Outcome of children with nodular lymphocyte predominant Hodgkin lymphoma - a Children's Cancer and Leukaemia Group report.
Hall GW; Katzilakis N; Pinkerton CR; Nicolin G; Ashley S; McCarthy K; Daw S; Hewitt M; Wallace WH; Shankar A
Br J Haematol; 2007 Sep; 138(6):761-8. PubMed ID: 17760808
[TBL] [Abstract][Full Text] [Related]
22. Race-specific features and outcomes of nodular lymphocyte-predominant Hodgkin lymphoma: Analysis of the National Cancer Data Base.
Olszewski AJ; Shrestha R; Cook NM
Cancer; 2015 Oct; 121(19):3472-80. PubMed ID: 26149294
[TBL] [Abstract][Full Text] [Related]
23. Advanced stage nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents: clinical characteristics and treatment outcome - a report from the SFCE & CCLG groups.
Shankar AG; Roques G; Kirkwood AA; Lambilliotte A; Freund K; Leblanc T; Hayward J; Abbou S; Ramsay AD; Schmitt C; Gorde-Grosjean S; Pacquement H; Haouy S; Boudjemaa S; Aladjidi N; Hall GW; Landman-Parker J
Br J Haematol; 2017 Apr; 177(1):106-115. PubMed ID: 28220934
[TBL] [Abstract][Full Text] [Related]
24. Does histology influence outcome in childhood Hodgkin's disease? Results from the United Kingdom Children's Cancer Study Group.
Shankar AG; Ashley S; Radford M; Barrett A; Wright D; Pinkerton CR
J Clin Oncol; 1997 Jul; 15(7):2622-30. PubMed ID: 9215833
[TBL] [Abstract][Full Text] [Related]
25. Clinico-Hematological Findings for Classical Hodgkin's Lymphoma: an Institutional Experience.
Sultan S; Irfan SM; Parveen S; Ali S
Asian Pac J Cancer Prev; 2016; 17(8):4009-11. PubMed ID: 27644653
[TBL] [Abstract][Full Text] [Related]
26. Hodgkin lymphoma: clinicopathologic features in Benin City, Nigeria and update on its biology and classification.
Olu-Eddo AN; Omoti CE
Niger J Clin Pract; 2011; 14(4):440-4. PubMed ID: 22248946
[TBL] [Abstract][Full Text] [Related]
27. A 20-year population-based study on the epidemiology, clinical features, treatment, and outcome of nodular lymphocyte predominant Hodgkin lymphoma.
Strobbe L; Valke LL; Diets IJ; van den Brand M; Aben K; Raemaekers JM; Hebeda KM; van Krieken JH
Ann Hematol; 2016 Feb; 95(3):417-23. PubMed ID: 26732883
[TBL] [Abstract][Full Text] [Related]
28. A chemotherapy only therapeutic approach to pediatric Hodgkin lymphoma: AHOPCA LH 1999.
Castellanos EM; Barrantes JC; Báez LF; Gamboa Y; Peña A; Alabi S; Bonilla M; Wang H; Metzger ML; de Alarcón PA
Pediatr Blood Cancer; 2014 Jun; 61(6):997-1002. PubMed ID: 24347509
[TBL] [Abstract][Full Text] [Related]
29. Management of Hodgkin's disease in western India.
Dinshaw KA; Advani SH; Gopal R; Nair CN; Talvalkar GV; Gangadharan P; Desai PB
Cancer; 1984 Oct; 54(7):1276-82. PubMed ID: 6467152
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics and outcome of pediatric patients with stage IV Hodgkin lymphoma.
Belgaumi A; Al-Kofide AA; Khafaga Y; Joseph N; Jamil-Malik R; Siddiqui KS; Sabbah RS
Hematol Oncol Stem Cell Ther; 2009; 2(1):278-84. PubMed ID: 20063558
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors in Hodgkin's disease. I. Analysis of histopathology, stage distribution and results of therapy.
Björkholm M; Holm G; Mellstedt H; Johansson B; Askergren J; Söderberg G
Scand J Haematol; 1977 Nov; 19(5):487-95. PubMed ID: 594663
[TBL] [Abstract][Full Text] [Related]
32. [Lymphomas in adolescents: are childhood lymphoma therapy protocols suitable for this patient group?].
Bence Z; Kovács G; Jakab Z; Csóka M; Müller J
Magy Onkol; 2008 Dec; 52(4):357-62. PubMed ID: 19068463
[TBL] [Abstract][Full Text] [Related]
33. Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials.
Shimabukuro-Vornhagen A; Haverkamp H; Engert A; Balleisen L; Majunke P; Heil G; Eich HT; Stein H; Diehl V; Josting A
J Clin Oncol; 2005 Aug; 23(24):5739-45. PubMed ID: 16009944
[TBL] [Abstract][Full Text] [Related]
34. [Clinical analysis of 135 newly diagnosed patients with Hodgkin lymphoma].
Zhou J; Wu X; Dai Y; Liu T; Xu C
Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):304-8. PubMed ID: 24759017
[TBL] [Abstract][Full Text] [Related]
35. Hodgkin's disease in Indian children: outcome with chemotherapy alone.
Arya LS; Dinand V; Thavaraj V; Bakhshi S; Dawar R; Rath GK; Singh R; Vats TS
Pediatr Blood Cancer; 2006 Jan; 46(1):26-34. PubMed ID: 16161019
[TBL] [Abstract][Full Text] [Related]
36. Hodgkin disease in ataxia-telangiectasia patients with poor outcomes.
Sandoval C; Swift M
Med Pediatr Oncol; 2003 Mar; 40(3):162-6. PubMed ID: 12518345
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcome after radiotherapy alone for lymphocyte-predominant Hodgkin lymphoma: a retrospective multicenter study of the Australasian Radiation Oncology Lymphoma Group.
Wirth A; Yuen K; Barton M; Roos D; Gogna K; Pratt G; Macleod C; Bydder S; Morgan G; Christie D
Cancer; 2005 Sep; 104(6):1221-9. PubMed ID: 16094666
[TBL] [Abstract][Full Text] [Related]
38. A review of histology of bone marrow trephine in malignant lymphomas.
Durosinmi MA; Mabayoje VO; Akinola NO
Niger J Med; 2003; 12(4):198-201. PubMed ID: 14768193
[TBL] [Abstract][Full Text] [Related]
39. Utility of bone marrow biopsy at diagnosis in pediatric Hodgkin's lymphoma.
Hines-Thomas MR; Howard SC; Hudson MM; Krasin MJ; Kaste SC; Shulkin BL; Metzger ML
Haematologica; 2010 Oct; 95(10):1691-6. PubMed ID: 20494933
[TBL] [Abstract][Full Text] [Related]
40. Classical Hodgkin lymphoma, lymphocyte depleted type: clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma.
Karube K; Niino D; Kimura Y; Ohshima K
Pathol Res Pract; 2013 Apr; 209(4):201-7. PubMed ID: 23478005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
